Braghi, S <br/><br/>
Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes.  [electronic resource] 

 -  Diabetes  Feb 2000 
 - 218-24 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0012-1797 
<br/><br/><label>Standard No.: </label>10.2337/diabetes.49.2.218  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibody Formation<br/>Autoantibodies--analysis<br/>Autoantigens--analysis<br/>Autoimmunity--immunology<br/>Diabetes Mellitus, Type 1--immunology<br/>Epitopes--immunology<br/>Glutamate Decarboxylase--immunology<br/>Graft Survival--immunology<br/>Humans<br/>Middle Aged<br/>Pancreas Transplantation--immunology<br/>Postoperative Period<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 1<br/>Protein Tyrosine Phosphatases--immunology<br/>Transplantation, Homologous<br/>Treatment Outcome